Publications by authors named "Helga Engi"

Claim this Profile
L
Low-grade oncocytic tumor of the kidney-a clinical, pathological, and next generation sequencing-based study of 20 tumors.
Alex Jenei, Boglárka Pósfai, Borbála Dénes, Áron Somorácz, Gertrud Forika, Helga Engi

Pathol Oncol Res· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of comprehensive genomic profiling on the diagnosis and clinical management of malignant mesenchymal tumours.
Anna Beáta Csepregi, Eszter Papp, Imola Adamik, Erzsébet Csernák, Helga Engi

Pathol Oncol Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Molecular pathology of lung adenocarcinomas, EGFR T790M resistance mutation study].
Andrea Kohánka, László Báthory-Fülöp, Eszter Tanács-Bencze, Helga Engi, Krisztina Bogos

Magy Onkol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[The importance of liquid biopsy studies in solid tumours].
Helga Engi, Erika Tóth

Magy Onkol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of two disiloxanes ALIS-409 and ALIS-421 on chemoprevention in model experiments.
Harukuni Tokuda, Takashi Maoka, Nobutaka Suzuiki, Judit Hohmann, Andrea Vasas, Helga Engi

Anticancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modelling of tumour--host coexistence In vitro in the presence of serine protease inhibitors.
Helga Engi, Nóra Gyémánt, Motohiro Ohkoshi, Leonard Amaral, Joseph Molnár

In Vivo· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of tomato lectin with ABC transporter in cancer cells: glycosylation confers functional conformation of P-gp.
Joseph Molnár, Meltem Demirel Kars, Ufuk Gündüz, Helga Engi, Udo Schumacher

Acta Histochem· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Perspectives of inhibition of multidrug resistance during cancer chemotherapy, in vitro and in vivo experiments].
Helga Engi

Orv Hetil· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of human cytomegalovirus IE gene expression by dihydro-beta-agarofuran sesquiterpenes isolated from Euonymus species.
Rozália Pusztai, Judit Hohmann, Dora Rédei, Helga Engi, Joseph Molnár

In Vivo· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemoprevention and inhibition of P-glycoprotein in cancer cells by Chinese medicinal herbs.
Helga Engi, Judit Hohmann, Geng Gang, Rozália Pusztai, Dóra Rédei

Phytother Res· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MDR-reversal activity of chalcones.
Antoaneta Ivanova, Daniela Batovska, Helga Engi, Stoyan Parushev, Imre Ocsovszki

In Vivo· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New MDR modulators and apoptosis inducers from Euphorbia species.
Helga Engi, Andrea Vasas, Dóra Rédei, Joseph Molnár, Judit Hohmann

Anticancer Res· November 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Review. Comparison of multidrug resistant efflux pumps of cancer and bacterial cells with respect to the same inhibitory agents.
Leonard Amaral, Helga Engi, Miguel Viveiros, Joseph Molnar

In Vivo· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of nontoxic heat shock protein 90 inhibitor peptide derivatives on reversal of MDR of tumor cells.
Joseph Molnár, Helga Engi, Yvette Mándi, Csaba Somlai, Botond Penke

In Vivo· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAR beta2 suppression in head and neck squamous cell carcinoma correlates with site, histology and age.
Judit Olasz, Alíz Juhász, Eva Remenár, Helga Engi, Mihály Bak

Oncol Rep· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interpretation of mtDNA RFLP variability among Aspergillus tubingensis isolates.
Akos Juhász, Helga Engi, Ilona Pfeiffer, Judit Kucsera, Csaba Vágvölgyi

Antonie Van Leeuwenhoek· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Macrocyclic lathyrane diterpenes as antitumor promoters.
Rozália Pusztai, Maria-José U Ferreira, Noélia Duarte, Helga Engi, Joseph Molnar

Anticancer Res· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumour-specific cytotoxicity and MDR-reversal activity of dihydropyridines.
Helga Engi, Hiroshi Sakagami, Masami Kawase, Alpesh Parecha, Dinesh Manvar

In Vivo· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cinnamylidene ketones as potential modulators of multidrug resistance in mouse lymphoma and human colon cancer cell lines.
Helga Engi, Nóra Gyémánt, Tamás Lóránd, Albert Lévai, Imre Ocsovszki

In Vivo· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preliminary studies on phenothiazine-mediated reversal of multidrug resistance in mouse lymphoma and COLO 320 cells.
Beata Pajak, Joseph Molnar, Helga Engi, Arkadiusz Orzechowski

In Vivo· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis